BlackRock Investment Management’s Microbot Medical MBOT Stock Holding History

BlackRock Investment Management’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-15	Closed	-$3K	–	3969
2016 Q3	$3K	Buy	+15	New	+$1.96K	﹤0.01%	3849
2016 Q2	–	Sell	-3	Closed	-$1K	–	4086
2016 Q1	$1K	Buy	+3	New	+$1.58K	﹤0.01%	4022
2015 Q2	–	Sell	-7	Closed	-$12K	–	4158
2015 Q1	$12K	Hold	7	–	–	﹤0.01%	3588
2014 Q4	$11K	Hold	7	–	–	﹤0.01%	3642
2014 Q3	$15K	Buy	7 +2	+40%	+$5.28K	﹤0.01%	3509
2014 Q2	$18K	Buy	+5	New	+$11.5K	﹤0.01%	3438

Other funds holding MBOT

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BlackRock Investment Management's MBOT Position: Q4 2016 in Review

BlackRock Investment Management sold out of Microbot Medical (MBOT) in Q4 2016, closing a stake of 15 shares — an estimated $3K sold.

BlackRock Investment Management first reported a position in MBOT in Q2 2014 and held it in 6 quarters. The position peaked at $18K in Q2 2014. 18 funds tracked by Wall St. Rank hold MBOT as of Q4 2016.

BlackRock Investment Management reported no remaining Microbot Medical position as of Q4 2016 after selling out during the quarter.
BlackRock Investment Management sold 15 Microbot Medical shares in Q4 2016, an estimated $3K.
BlackRock Investment Management first reported a position in Microbot Medical in Q2 2014 and held it in 6 quarters.
BlackRock Investment Management's Microbot Medical position peaked at $18K in Q2 2014.
18 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.